Journal article

Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein


Authors listSosic, A; Olivato, G; Carraro, C; Göttlich, R; Fabris, D; Gatto, B

Publication year2021

Pages1874-

JournalMolecules

Volume number26

Issue number7

Open access statusGold

DOI Linkhttps://doi.org/10.3390/molecules26071874

PublisherMDPI


Abstract
Specific RNA sequences regulate functions essential to life. The Trans-Activation Response element (TAR) is an RNA stem-bulge-loop structure involved in several steps of HIV-1 replication. In this work, we show how RNA targeting can inhibit HIV-1 nucleocapsid (NC), a highly conserved protein known to catalyze nucleic acid melting and strand transfers during reverse transcription. Our RNA targeting strategy consists of the employment of bis-3-chloropiperidines (B-CePs) to impair RNA melting through bifunctional alkylation. Specific interactions between B-CePs and TAR RNA were analytically investigated by gel electrophoresis and mass spectrometry, allowing the elucidation of B-CePs' recognition of TAR, and highlighting an RNA-directed mechanism of protein inhibition. We propose that B-CePs can freeze TAR tridimensional conformation, impairing NC-induced dynamics and finally inhibiting its functions in vitro.



Citation Styles

Harvard Citation styleSosic, A., Olivato, G., Carraro, C., Göttlich, R., Fabris, D. and Gatto, B. (2021) Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein, Molecules, 26(7), p. 1874. https://doi.org/10.3390/molecules26071874

APA Citation styleSosic, A., Olivato, G., Carraro, C., Göttlich, R., Fabris, D., & Gatto, B. (2021). Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein. Molecules. 26(7), 1874. https://doi.org/10.3390/molecules26071874


Last updated on 2025-10-06 at 11:24